Kansas will receive $922,000 in Walgreens settlement

Company allegedly over-dispensed insulin pens
Kansas will receive $922,000 in Walgreens settlement

Kansas will receive nearly a million dollars as its part of a national settlement with Walgreens concerning over-dispensing of insulin pens to Medicare and Medicaid beneficiaries.

Attorney General Derek Schmidt’s office said in a news release the settlement resolves allegations that from January 1, 2006, through December 31, 2017, Walgreens repeatedly dispensed more insulin than had been prescribed to patients. The company was accused of then falsifying information on claims submitted for reimbursement to Medicare and Medicaid to obtain payment for the larger quantities.

Schmidt said Walgreens agreed to pay the U.S. and states $209.2 million, with $89.1 million going to state Medicaid programs. Kansas will receive $922,126 which will be used to reimburse federal and state funds spent by the Kansas Medicaid program, and to recover the cost of the investigation that led to the settlement.